Using transgenic mice that overexpress soluble TWEAK, we have shown that the soluble form of TWEAK has a pro-neuroinflammatory effect in an animal model of multiple sclerosis (MS) [9]. The gene discussed is TNFSF12; the disease is myeloid sarcoma.